Price Targets For Oncopeptides

Stockholm Stock Exchange

Oncopeptides

+319.53% (4.19)

RedeyeDNBDNB MarketsCarnegieABG Sundal CollierKempenSEB Equities

Latest Target

+319.53%

5.50 SEK

Redeye

Aug -25

5.50 SEK

All Price Targets For Oncopeptides

Redeye

Aug -25

Target: 5.50 SEKPrice: 1.31 SEK

+319.53%

DNB

Feb -25

Target: 2.00 SEKPrice: 1.31 SEK

+52.56%

DNB Markets

Jun -24

Target: 5.50 SEKPrice: 1.31 SEK

+319.53%

Carnegie

Nov -23

Target: 6.80 SEKPrice: 1.31 SEK

+418.69%

ABG Sundal Collier

Sep -22

Target: 12.00 SEKPrice: 1.31 SEK

+815.33%

Kempen

Jul -22

Target: 35.00 SEKPrice: 1.31 SEK

+2569.72%

SEB Equities

Oct -21

Target: 0.35 SEKPrice: 1.31 SEK

-73.30%

About The Company

Oncopeptides AB is a Swedish pharmaceutical company that develops drugs for the treatment of cancer. It was founded in 2000, based on cancer research and supported by Healthcap, Industrifonden and Karolinska Institutet. Oncopeptode’s shares have been listed on the Stockholm Stock Exchange’s main list since 2017.
Wikipedia